За пациентите, приемащи Kaletra все още има риск да развият инфекции или други заболявания, свързани с HIV и СПИН.
A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances.